Description

12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-1 1-oxo-3-[[4-[2-(2-oxo-3-oxazolidinyl)ethoxy]phenyl]methyl]-9-(phenylmethyl)-, 1,1-dimethylethyl ester, [3S-(3R*,4S*,8S*,9R*)]- is a complex, stereochemically defined heterocyclic compound designed for advanced synthetic applications. This high-purity chemical building block is critical for researchers and developers working on novel active pharmaceutical ingredients (APIs) and fine chemicals. It is primarily utilized in pharmaceutical R&D, particularly in the synthesis of sophisticated molecules with specific biological activity.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of new therapeutic agents, particularly for complex target molecules.
• Advanced Organic Synthesis: Serves as a versatile building block for constructing complex polyheterocyclic frameworks in academic and industrial research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes due to its defined stereochemistry and functional groups.
• Process Chemistry Development: Employed in scaling up synthetic routes for potential APIs, requiring consistent high purity and reliable supply.
• Bioconjugation & Probe Synthesis: Potential use in creating labeled compounds or probes for biochemical and diagnostic research applications.

Basic Information

Item	Details
Product Name	12-Oxa-2,6,10-triazatetradecanoic acid, 4,8-dihydroxy-13,13-dimethyl-1 1-oxo-3-[[4-[2-(2-oxo-3-oxazolidinyl)ethoxy]phenyl]methyl]-9-(phenylmethyl)-, 1,1-dimethylethyl ester, [3S-(3R*,4S*,8S*,9R*)]-
CAS No.	162540-90-1
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	tert-Butyl (3S,4S,8S,9R)-4,8-dihydroxy-13,13-dimethyl-11-oxo-3-[[4-[2-(2-oxo-3-oxazolidinyl)ethoxy]phenyl]methyl]-9-(phenylmethyl)-12-oxa-2,6,10-triazatetradecanoate; BILN 2061 ZW; BILN-2061; BILN 2061; Ciluprevir intermediate; (3S,4S,8S,9R)-tert-Butyl 4,8-dihydroxy-13,13-dimethyl-11-oxo-3-((4-(2-(2-oxooxazolidin-3-yl)ethoxy)benzyl)carbamoyl)-9-(phenylmethyl)-12-oxa-2,6,10-triazatetradecanoate
EINECS	Contact for details

Quality Control

Our 12-Oxa-2,6,10-triazatetradecanoic acid derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and chiral purity assessment, to ensure it meets the exacting standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and compliance with your internal specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Purity (HPLC)	≥ 97.0%
Chiral Purity	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.